Results 1 to 10 of about 15,868 (218)
【目的】评估门诊高血压患者不同血压控制水平间容量负荷的差异,探讨门诊高血压患者的临床因素对容量负荷的影响,分析门诊高血压患者临床基线特点及降压药物使用情况。【方法】在2017年7月至11月期间,纳入门诊高血压患者共514例。记录患者的临床指标,包括性别、年龄、身高、体质量、高血压年限、血压水平、高血压治疗方案及合并症情况。采用生物阻抗分析仪,检测细胞外液与身体总水比值(ECW/TBW),对人体容量负荷进行评估,全身ECW/TBW≥0.39定义为高容量负荷。分析各种临床因素对高血压患者容量负荷的影响 ...
罗艳婷+3 more
doaj +2 more sources
目的:经临床研究探讨全科医生对高血压患者的临床疗效发挥的作用,希望能够为广大医患带来启发与借鉴。方法:此实验的研究时间集中在2021.5-2023.5之间,随机抽取我院收治的100例高血压病人,根据随机分组法将其设置成2组:对照组和实验组,其对应的患者人数各是50例,两组患者均在临床医生的指导下进行降压治疗,其中,实验组患者需要在全科医生的指导下展开综合性治疗,通过12个月的临床随访与观察,统计对比2组患者的病情控制效果、临床不良反应率等。结果:经过12个月的临床治疗及随访发现 ...
嘉聪 施
semanticscholar +1 more source
目的 通过临床资料整理了解高血压患者选择沙库巴曲缬沙坦钠片进行疾病治疗的应用效果。方法 抽取我院在2023.1-2023.9期间接收的高血压病人80例为调查对象,以随机分组的方式将其划分成2个小组:实验组和对照组,每小组病患例数均等,各是40例,其中,对照组患者采用的是硝苯地平缓释片,实验组患者采用的是硝苯地平缓释片与沙库巴曲缬沙坦,所有患者的治疗时间是2个月,然后对比2组的治疗效果。结果 实验组患者的治疗效率是95.00%远远超过对照组72.50%(P<0.05),数据比较有差异。在治疗前 ...
高锋 司徒
semanticscholar +1 more source
Highlights The Blood Pressure Control Target in Diabetes (BPROAD) study is a multicenter, randomized controlled trial conducted in mainland China to test the hypothesis of whether intensive blood pressure (BP) management (systolic BP <120 mm Hg) has additional benefits over standard BP management (systolic BP <140 mm Hg) over a follow‐up period of up ...
The BPROAD Study Group+18 more
wiley +1 more source
Highlights The optimal blood pressure (BP) target in patients with type 2 diabetes mellitus (T2DM) for the management of cognitive decline remains unknown. The Blood Pressure Control Target in Diabetes (BPROAD) Cognitive Study was designed to determine whether intensive BP treatment (systolic BP <120 mm Hg) reduces risk of dementia and mild cognitive ...
The BPROAD Study Group+18 more
wiley +1 more source
Highlights We identified that CGM can increase motivation for self‐management and confidence in treatments. A supportive treating team may help to reduce the practical and psychological burden in patients with type 1 and type 2 diabetes. Abstract Aims Blood glucose control is central to the management of diabetes, and continuous glucose monitoring (CGM)
Patrizia Natale+10 more
wiley +1 more source
ABSTRACT Objectives To identify all prediction models for fetal and neonatal outcomes in pregnancies with preterm manifestations of placental insufficiency (gestational hypertension, pre‐eclampsia, HELLP syndrome or fetal growth restriction with its onset before 37 weeks' gestation) and to assess the quality of the models and their performance on ...
D. G. Kleuskens+8 more
wiley +1 more source
Successful surgical removal of a pheochromocytoma in a mare via trans‐costal approach
Abstract Background Pheochromocytomas have been previously reported in horses, but successful antemortem diagnosis and surgical removal without recurrence of clinical signs have not been described. Objective To report the clinical presentation, diagnostic evaluation, surgical technique, anaesthetic management and post‐operative care of a mare diagnosed
Thomas J. O'Brien+6 more
wiley +1 more source
Glycosylated fibronectin improves first‐trimester prediction of pre‐eclampsia
ABSTRACT Objective To determine whether maternal serum glycosylated fibronectin (GlyFn) level in the first trimester increases the sensitivity of the Fetal Medicine Foundation (FMF) triple test, which incorporates mean arterial pressure, uterine artery pulsatility index and placental growth factor, when screening for pre‐eclampsia (PE) in an Asian ...
S. Moungmaithong+7 more
wiley +1 more source
Highlights Serum low‐density lipoprotein cholesterol (LDL‐C) levels were positively and significantly associated with a high risk of incident diabetes. Even in participants with normal LDL‐C levels (<130 mg/dL), a 1‐SD increase in LDL‐C levels was significantly associated with a higher risk of diabetes development.
Jiaojiao Huang+13 more
wiley +1 more source